Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04735978
Title Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumours
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Replimune Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GRC | GBR | FRA | ESP


No variant requirements are available.